Request a Mailed Copy
Program Overview:
CD Compass: Navigating the Evolving Treatment Landscape in CD is an independent learning tool that allows participants to gain comprehensive insights into Crohn's disease (CD) treatment strategies. Participants will develop an understanding of the evolving treatment goals in CD, assess the efficacy and safety of advanced therapies approved for CD in Canada, and learn how to apply clinical considerations to make informed decisions regarding the selection and sequencing of advanced therapies for CD management.
Accreditation Information:
- Self-Learning activity (Section 2)
- 1.0 Section 2 Credits - Scanning Activity per activity.
Program objectives are:
- Examine the efficacy and safety of novel treatment options in CD.
- Review clinical cases to identify the ideal patient populations for these novel treatments.
- Discuss the impact of clinical considerations on selecting and sequencing treatments for CD.
Scientific Planning Committee:
Steven Gruchy, MD, MSc, FRCPC, FACG, CAGF (CAG Educational Representative)
Robert Battat, MD, CM, FRCPC
Cynthia Seow, MBBS (Hons), MSc, FRACP
This resource is a Self-Learning activity (Section 2) as defined by the Maintenance of Certification Program of the Royal College and endorsed by the Canadian Association of Gastroenterology (CAG). This resource was co-developed with AbbVie and was developed to achieve scientific integrity, objectivity and balance.
